Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
14.08
0.11 (0.79%)
At close: Aug 21, 2025, 3:59 PM
13.60
-3.41%
Pre-market: Aug 22, 2025, 08:30 AM EDT
Tekla Life Sciences Investors Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | n/a | n/a | n/a | 477.00 | 822.00 | 445.00 | 292.4K | 990.00 | 159.00 |
Short-Term Investments | 12.16M | n/a | n/a | 15.24M | 11.98M | 32.94M | 22.42M | 17.17M | 1.05M |
Long-Term Investments | n/a | 460.3M | 429.95M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |
Other Long-Term Assets | n/a | 13.9M | 11.83M | n/a | -432.64M | -414.08M | -444.99M | -534.01M | -503.2M |
Receivables | 6.39M | 231.11K | 112.96K | 5.04M | 12.82K | 623.47K | 3.1M | 150.34K | 5.41K |
Inventory | n/a | n/a | n/a | n/a | 11.99M | 33.57M | 25.82M | -0.00 | 1.05M |
Other Current Assets | -18.55M | 8.97K | 8.97K | n/a | 2.65M | 11.09M | 13.94M | 8.46M | 1.05M |
Total Current Assets | n/a | 281.61K | 171.92K | 5.05M | 13.64K | 623.92K | 3.39M | 144.66K | 5.57K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 474.2M | 441.78M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |
Total Assets | 411.34M | 460.58M | 441.95M | 402.6M | 432.69M | 414.73M | 448.41M | 534.19M | 503.33M |
Account Payables | n/a | 1.79K | 229.3K | n/a | n/a | 5.1M | 3.54M | n/a | 44.08K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 5.09M | -5.15M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 50.81K | n/a | n/a | -10.04M | -5.1M | -3.54M | -9.4M | -44.08K |
Total Current Liabilities | n/a | 888.61K | 879.91K | n/a | 10.04M | 5.1M | 3.54M | 10.75M | 44.08K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 886.82K | 650.61K | 666.96K | n/a | n/a | -209.84K | -1.34M | n/a |
Total Long-Term Liabilities | n/a | 886.82K | 650.61K | 666.96K | 10.04M | 5.1M | 3.54M | 9.4M | 649.63K |
Total Liabilities | 15.4M | 888.61K | 879.91K | 666.96K | 10.04M | 16.82M | 12.94M | 10.75M | 649.63K |
Total Debt | n/a | n/a | n/a | n/a | 9.33K | 11.09K | 209.84K | 1.34M | n/a |
Common Stock | 288.72K | 280.61K | 273.5K | 267.91K | 262.12K | 256.8K | 251.44K | 246.68K | 242.79K |
Retained Earnings | -30.52M | 44.13M | 30.19M | -1.48M | 26.83M | 9.55M | 54.34M | 150.7M | 138.19M |
Comprehensive Income | n/a | n/a | n/a | n/a | 0.00 | -0.00 | 0.00 | 0.00 | n/a |
Shareholders Equity | 395.94M | 459.69M | 441.07M | 401.93M | 422.65M | 397.9M | 435.47M | 523.44M | 502.68M |
Total Investments | 12.16M | 460.3M | 429.95M | 397.53M | 432.64M | 414.08M | 444.99M | 534.01M | 503.2M |